Recent progresses in understanding pigmentation

Giornale Italiano di Dermatologia e Venereologia

Volumn 145, Issue 1, 2010, Pages 47-55

  Kosmadaki, M G ^a   Naif, A ^a   Park, Hee Young ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Melanocytes; Molecular biology; Pigmentation disorders

Indexed keywords

HORMONE; INTERLEUKIN 6; MELANIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; NITRIC OXIDE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

CELL FUNCTION; DOWN REGULATION; EPIGENETICS; GENE CONTROL; HUMAN; MELANOCYTE; MELANOGENESIS; MELANOSOME; PHENOTYPE; REVIEW; SKIN PIGMENTATION; ULTRAVIOLET RADIATION; UPREGULATION; VITILIGO;

EID: 77952367650     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (110)

1. Sturm RA, Teasdale RD, Box NF. Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene 2001;277:49-62.
2. Tomita Y, Suzuki T. Genetics of pigmentary disorders. Am J Med Genet C Semin Med Genet 2004;131C:75-81.
3. Hearing VJ. Biochemical control of melanogenesis and melanosomal organization. J Investig Dermatol Symp Proc 1999;4:24-28
4. Hearing VJ, Jimenez M. Mammalian tyrosinase - the critical regulatory control point in melanocyte pigmentation. Int J Biochem 1987;19:1141-1147
5. Prota G. Some new aspects of eumelanin chemistry. Prog Clin Biol Res 1988;256:101-124
6. Korner A, Pawelek J. Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 1982;217:1163-1165 (Pubitemid 12069041)
7. Jimenez-Cervantes C, Solano F, Kobayashi T, Urabe K, Hearing VJ, Lozano JA et al. A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). J Biol Chem 1994;269:17993-8000. (Pubitemid 24982643)
8. Kobayashi T, Urabe K, Winder A, Jiménez-Cervantes C, Imokawa G, Brewington T et al. Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. Embo J 1994;13:5818-25.
9. Jackson IJ, Chambers DM, Tsukamoto K, Copeland NG, Gilbert DJ, Jenkins NA, Hearing V. A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. Embo J 1992;11:527-535
10. Yokoyama K, Suzuki H, Yasumoto K, Tomita Y, Shibahara S. Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2. Biochim Biophys Acta 1994;1217:317-321 (Pubitemid 24113512)
11. Manga P, Kromberg JG, Box NF, Sturm RA, Jenkins T, Ramsay M. Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene. Am J Hum Genet 1997;61:1095-1101 (Pubitemid 27492317)
12. Okulicz JF, Shah RS, Schwartz RA, Janniger CK. Oculocutaneous albinism. J Eur Acad Dermatol Venereol 2003;17:251-256
13. Barton DE, Kwon BS, Francke U. Human tyrosinase gene, mapped to chromosome 11 (q14 - q21), defines second region of homology with mouse chromosome 7. Genomics 1988;3:17-24.
14. Kwon BS. Pigmentation genes: the tyrosinase gene family and the pmel 17 gene fantily. J Invest Dermatol 1993;100:134S-140S.
15. Muller G, Ruppert S, Schmid E, Schutz G. Functional analysis of alternatively spliced tyrosinase gene transcripts. Embo J 1988;7:2723-30.
16. Ruppert S, Muller G, Kwon B, Schutz G. Multiple transcripts of the mouse tyrosinase gene are generated by alternative splicing. Embo J 1988;7:2715-2722
17. Shibahara S, Tomita Y, Tagami H, Muller RM, Cohen T. Molecular basis for the heterogeneity of human tyrosinase. Tohoku J Exp Med 1988;156:403-414 (Pubitemid 19076871)
18. Porter S, Mintz B. Multiple alternatively spliced transcripts of the mouse tyrosinase-encoding gene. Gene 1991;97:277-282
19. Ponnazhagan S, Hou L, Kwon BS. Structural organization of the human tyrosinase gene and sequence analysis and characterization of its promoter region. J Invest Dermatol 1994;102:744-748 (Pubitemid 24144255)
20. Bentley NJ, Eisen T, Goding CR. Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol Cell Biol 1994;14:7996-8006. (Pubitemid 24373548)
21. Hodgkinson CA, Moore KJ, Nakayama A, Steingrimsson E, Copeland NG, Jenkins NA, Arnheiter H. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 1993;74:395-404. (Pubitemid 23221714)
22. Steingrímsson E, Moore KJ, Lamoreux ML, Ferré- D'Amaré AR, Burley SK, Zimring DC et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat Genet 1994;8:256-263
23. Kichina J, Green A, Rauth S. Tumor suppressor p53 down-regulates tissue-specific expression of tyrosinase gene in human melanoma cell lines. Pigment Cell Res 1996;9:85-91. (Pubitemid 126478573)
24. Khlgatian MK, Hadshiew IM, Asawanonda P, Yaar M, Eller MS, Fujita M et al. Tyrosinase gene expression is regulated by p53. J Invest Dermatol 2002;118:126-132 (Pubitemid 34107433)
25. Nylander K, Bourdon JC, Bray SE, Gibbs NK, Kay R, Hart I et al. Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation to the protective tanning response. J Pathol 2000;190:39-46. (Pubitemid 30053351)
26. Gilchrest BA, Park HY, Eller MS, Yaar M. Mechanisms of ultraviolet light-induced pigmentation. Photochem Photobiol 1996;63:1-10.
27. Tachibana M, Takeda K, Nobukuni Y, Urabe K, Long JE, Meyers KA et al. Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics. Nat Genet 1996;14:50-54 (Pubitemid 26301546)
28. Widlund HR, Fisher DE. Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene 2003;22:3035-3041
29. Hughes AE, Newton VE, Liu XZ, Read AP. A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nat Genet 1994;7:509-512
30. Tassabehji M, Newton VE, Read AP. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet 1994;8:251-255 (Pubitemid 24338736)
31. Amiel J, Watkin PM, Tassabehji M, Read AP, Winter RM. Mutation of the MITF gene in albinism-deafness syndrome (Tietz syndrome). Clin Dysmorphol 1998;7:17-20. (Pubitemid 28049398)
32. Smith SD, Kelley PM, Kenyon JB, Hoover D. Tietz syndrome (hypopigmentation/deafness) caused by mutation of MITF. J Med Genet 2000;37:446-448 (Pubitemid 30386737)
33. Anikster Y, Huizing M, Anderson PD, Fitzpatrick DL, Klar A, Gross-Kieselstein E E et al. Evidence that Griscelli syndrome with neurological involvement is caused by mutations in RAB27A, not MYO5A. Am J Hum Genet 2002;71:407-414 (Pubitemid 34800257)
34. Pastural E, Barrat FJ, Dufourcq-Lagelouse R, Certain S, Sanal O, Jabado N et al. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet 1997;16:289-292 (Pubitemid 27280214)
35. Ménasché G, Ho CH, Sanal O, Feldmann J, Tezcan I, Ersoy F. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest 2003;112:450-456 (Pubitemid 38063774)
36. Hughes MJ, Lingrel JB, Krakowsky JM, Anderson KP. A helix-loop-helix transcription factor-like gene is located at the mi locus. J Biol Chem 1993;268:20687-20690
37. Hemesath TJ, Steingrimsson E, McGill G, Hansen MJ, Vaught J, Hodgkinson CA et al. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 1994;8:2770-2780 (Pubitemid 24375425)
38. Shibahara S, Takeda K, Yasumoto K, Udono T, Watanabe K, Saito H et al. Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation. J Investig Dermatol Symp Proc 2001;6:99-104.
39. Yasumoto K, Amae S, Udono T, Fuse N, Takeda K, Shibahara S. A big gene linked to small eyes encodes multiple Mitf isoforms: many promoters make light work. Pigment Cell Res 1998;11:329-336 (Pubitemid 128531529)
40. Hershey CL, Fisher DE. Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function. Bone 2004;34:689-696
41. Amae S, Fuse N, Yasumoto K, Sato S, Yajima I, Yamamoto H et al. Identification of a novel isoform of microphthalmia-associated transcription factor that is enriched in retinal pigment epithelium. Biochem Biophys Res Commun 1998;247:710-715 (Pubitemid 28418456)
42. Yasumoto K, Yokoyama K, Takahashi K, Tomita Y, Shibahara S. Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes. J Biol Chem 1997;272:503-509 (Pubitemid 27021187)
43. Furumura, M., Potterf, S.B., Toyofuku, K., Matsunaga, J., Muller, J. and Hearing, V.J. (2001). Involvement of ITF2 in the transcriptional regulation of melanogenic genes. J Biol Chem 276, 28147-28154 (Pubitemid 37391517)
44. Jacquemin P, Lannoy VJ, O'Sullivan J, Read A, Lemaigre FP, Rousseau GG. The transcription factor onecut-2 controls the microphthalmia-associated transcription factor gene. Biochem Biophys Res Commun 2001;285:1200-1205 (Pubitemid 32912908)
45. Dorsky RI, Raible DW, Moon RT. Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev 2000;14:158-162
46. Takeda K, Yasumoto K, Takada R, Takada S, Watanabe K, Udono T et al. Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a. J Biol Chem 2000;275:14013-14016 (Pubitemid 30339673)
47. Saito H, Yasumoto K, Takeda K, Takahashi K, Yamamoto H, Shibahara S. Microphthalmia-associated transcription factor in the Wnt signaling pathway. Pigment Cell Res 2003;16:261-265 (Pubitemid 36597066)
48. Staal FJ, Noort Mv M, Strous GJ, Clevers HC. Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep 2002;3:63-68
49. Yasumoto K, Takeda K, Saito H, Watanabe K, Takahashi K, Shibahara S. Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. Embo J 2002;21:2703-2714 (Pubitemid 34619386)
50. Dorsky RI, Moon RT, Raible DW. Control of neural crest cell fate by the Wnt signalling pathway. Nature 1998;396:370-373
51. Ikeya M, Lee SM, Johnson JE, McMahon AP, Takada S. Wnt signalling required for expansion of neural crest and CNS progenitors. Nature 1997;389:966-970 (Pubitemid 27485687)
52. van Genderen C, Okamura RM, Farinas I, Quo RG, Parslow TG, Bruhn L et al. Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev 1994;8:2691-2703 (Pubitemid 24375419)
53. Galibert MD, Yavuzer U, Dexter TJ, Goding CR. Pax3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter. J Biol Chem 1999;274:26894-26900 (Pubitemid 129520210)
54. Watanabe A, Takeda K, Ploplis B, Tachibana M. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nat Genet 1998;18:283-286 (Pubitemid 28117270)
55. Tassabehji M, Read AP, Newton VE, Patton M, Gruss P, Harris R et al. Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2. Nat Genet 1993;3:26-30.
56. Tassabehji M, Read AP, Newton VE, Harris R, Balling R, Gruss P et al. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 1992;355:635-636
57. Southard-Smith EM, Kos L, Pavan WJ. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet 1998;18:60-64 (Pubitemid 28027881)
58. Kuhlbrodt K, Schmidt C, Sock E, Pingault V, Bondurand N, Goossens M et al. Functional analysis of Sox10 mutations found in human Waardenburg- Hirschsprung patients. J Biol Chem 1998;273:23033-23038
59. Potterf SB, Furumura M, Dunn KJ, Arnheiter H, Pavan WJ. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum Genet 2000;107:1-6. (Pubitemid 30598938)
60. Lee M, Goodall J, Verastegui C, Ballotti R, Goding CR. Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J Biol Chem 2000;275:37978-37983 (Pubitemid 32004919)
61. Pingault V, Pingault V, Bondurand N, Kuhlbrodt K, Goerich DE, Préhu MO, Puliti A et al. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 1998;18:171-173 (Pubitemid 28082467)
62. Price ER, Horstmann MA, Wells AG, Weilbaecher KN, Takemoto CM, Landis MW et al. Alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J Biol Chem 1998;273:33042-33047
63. Bertolotto C, Abbe P, Hemesath TJ, Bille K, Fisher DE, Ortonne JP et al. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol 1998;142:827-835 (Pubitemid 28381498)
64. Fuse N, Yasumoto K, Suzuki H, Takahashi K, Shibahara S. Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene. Biochem Biophys Res Commun 1996;219:702-707 (Pubitemid 26106749)
65. Hagiwara M, Alberts A, Brindle P, Meinkoth J, Feramisco J, Deng T et al. Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB. Cell 1992;70:105-113
66. Wadzinski BE, Wheat WH, Jaspers S, Peruski LF, Jr, Lickteig RL, Johnson GL et al. Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol Cell Biol 1993;13:2822-2834 (Pubitemid 23133954)
67. Armstrong R, Wen W, Meinkoth J, Taylor S, Montminy M. A refractory phase in cyclic AMP-responsive transcription requires down regulation of protein kinase A. Mol Cell Biol 1995;15:1826-1832
68. Goding CR. Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev 2000;14:1712-1728
69. Hemesath TJ, Price ER, Takemoto C, Badalian T, Fisher DE. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature 1998;391:298-301. (Pubitemid 28099019)
70. Wu M, Hemesath TJ, Takemoto CM, Horstmann MA, Wells AG, Price ER et al. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev 2000;14:301-312 (Pubitemid 30106485)
71. Sato S, Roberts K, Gambino G, Cook A, Kouzarides T, Goding CR. CBP/p300 as a co-factor for the Microphthalmia transcription factor. Oncogene 1997;14:3083-3092 (Pubitemid 27336324)
72. Miller AJ, Levy C, Davis IJ, Razin E, Fisher DE. Sumoylation of MITF and Its Related Family Members TFE3 and TFEB. J Biol Chem 2005;280:146-155 (Pubitemid 40164975)
73. Tachibana, M. et al. (1994). Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.1-p12.3. Hum Mol Genet 1994;3:553-557 (Pubitemid 24122165)
74. Yasumoto K, Yokoyama K, Shibata K, Tomita Y, Shibahara S. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol Cell Biol 1994;14:8058-8070 (Pubitemid 24373554)
75. Aoki H, Moro O. Involvement of microphthalmia-associated transcription factor (MITF) in expression of human melanocortin-1 receptor (MC1R). Life Sci 2002;71:2171-2179
76. Carreira S, Liu B, Goding CR. The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes. J Biol Chem 2000;275:21920-21927 (Pubitemid 30621764)
77. Baxter LL, Pavan WJ. Pmel17 expression is Mitf-dependent and reveals cranial melanoblast migration during murine development. Gene Expr Patterns 2003;3:703-707
78. Du J, Miller AJ, Widlund HR, Horstmann MA, Ramaswamy S, Fisher DE. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am J Pathol 2003;163:333-343 (Pubitemid 36759618)
79. Du J, Fisher DE. Identification of Aim-1 as the underwhite mouse mutant and its transcriptional regulation by MITF. J Biol Chem 2002;277:402-406 (Pubitemid 34952072)
80. McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, Nishimura EK et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 2002;109:707-718 (Pubitemid 34722267)
81. Gilchrest BA, Eller MS. DNA photodamage stimulates melanogenesis and other photoprotective responses. J Investig Dermatol Symp Proc 1999;4:35-40.
82. Parrish JA, Jaenicke KF, Anderson RR. Erythema and melanogenesis action spectra of normal human skin. Photochem Photobiol 1982;36:187-191 (Pubitemid 12037234)
83. Freeman SE, Hacham H, Gange RW, Maytum DJ, Sutherland JC, Sutherland BM. Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet tight. Proc Natl Acad Sci U S A 1989;86:5605-5609 (Pubitemid 19185593)
84. Gilchrest BA, Zhai S, Eller MS, Yarosh DB, Yaar M. Treatment of human melanocytes and S91 melanoma cells with the DNA repair enzyme T4 endonuclease V enhances melanogenesis after ultraviolet irradiation. J Invest Dermatol 1993;101:666-672 (Pubitemid 23322021)
85. Eller MS, Ostrom K, Gilchrest BA. DNA damage enhances melanogenesis. Proc Natl Acad Sci U S A 1996;93:1087-1092 (Pubitemid 26052846)
86. Eller MS, Yaar M, Gilchrest BA. DNA damage and melanogenesis. Nature 1994;372:413-414
87. Hadshiew IM, Eller MS, Gasparro FP, Gilchrest BA. Stimulation of melanogenesis by DNA oligonucleotides: effect of size, sequence and 5′ phosphorylation. J Dermatol Sci 2001;25:127-138
88. Punnonen K, Yuspa SH. Ultraviolet light irradiation increases cellular diacylglycerol and induces translocation of diacylglycerol kinase in murine keratinocytes. J Invest Dermatol 1992;99:221-226
89. Park HY, Perez JM, Laursen R, Hara M, Gilchrest BA. Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain. J Biol Chem 1999;274:16470-16478 (Pubitemid 129526403)
90. Park HY, Wu H, Killoran CE, Gilchrest BA. The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-beta on melanosomes. J Cell Sci 2004;117:3659-3668 (Pubitemid 39206405)
91. Gordon PR, Gilchrest BA. Human melanogenesis is stimulated by diacylglycerol. J Invest Dermatol 1989;93:700-702
92. Allan AE, Archambault M, Messana E, Gilchrest BA. Topically applied diacylglycerols increase pigmentation in guinea pig skin. J Invest Dermatol 1995;105:687-692
93. Park HY, Lee J, Gonzalez S, Middelkamp-Hup MA, Kapasi S, Peterson S, Gilchrest BA. Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation. J Invest Dermatol 2004;122:159-166 (Pubitemid 38114653)
94. Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 2004;17:96-110. (Pubitemid 38419636)
95. Wong G, Pawelek J. Melanocyte-stimulating hormone promotes activation of pre-existing tyrosinase molecules in Cloudman S91 melanoma cells. Nature 1975;255:644-646
96. Abdel Malek ZA, Kreutzfeld KL, Marwan MM, Hadley ME, Hruby VJ, Wilkes BC. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins. Cancer Res 1985;45:4735-4740
97. Ao Y, Park HY, Olaizola-Horn S, Gilchrest BA. Activation of cAMP-dependent protein kinase is required for optimal alpha-melanocyte- stimulating hormone-induced pigmentation. Exp Cell Res 1998;244:117-124 (Pubitemid 28480860)
98. Imokawa G, Yada Y, Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 1992;267:24675-24680
99. Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol 1995;105:32-37
100. Scott MC, Suzuki I, Abdel-Malek ZA. Regulation of the human melanocortin 1 receptor expression in epidermal melanocytes by paracrine and endocrine factors and by ultraviolet radiation. Pigment Cell Res 2002;15:433-439 (Pubitemid 35374625)
101. Tada A, Suzuki I, Im S, Davis MB, Cornelius J, Babcock G et al. Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. Cell Growth Differ 1998;9:575-584 (Pubitemid 28345914)
102. Funasaka Y, Chakraborty AK, Hayashi Y, Komoto M, Ohashi A, Nagahama M et al. Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-1 alpha, interleukin-1beta, endothelin-1 and tumour necrosis factor-alpha. Br J Dermatol 1998;139:216-224 (Pubitemid 28389393)
103. Jo HY, Kim CK, Suh IB, Ryu SW, Ha KS, Kwon YG et al. Co-localization of inducible nitric oxide synthase and phosphorylated Akt in the lesional skins of patients with melasma. J Dermatol 2009;36:10-6.
104. Oka M, Nagai H, Ando H, Fukunaga M, Matsumura M, Araki K et al. Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells. J Invest Dermatol 2000;115:699-703.
105. Abdel-Malek ZA, Knittel J, Kadekaro AL, Swope VB, Starner R. The melanocortin 1 receptor and the UV response of human melanocytes - a shift in paradigm. Photochem Photobiol 2008;84:501-508 (Pubitemid 351421403)
106. Maeda K, Naganuma M, Fukuda M, Matsunaga J, Tomita Y. Effect of pituitary and ovarian hormones on human melanocytes in vitro. Pigment Cell Res 1996;9:204-212 (Pubitemid 126478637)
107. McLeod S, Hand L, Rosenthal JB, Hayes B. The effect of sampling condition on children's productions of consonant clusters. J Speech Hear Res 1994;37:868-882 (Pubitemid 24251164)
108. Schallreuter KU, Kothari S, Chavan B, Spencer JD. Regulation of melanogenesis - controversies and new concepts. Exp Dermatol 2008;17:395-404. (Pubitemid 351513953)
109. Choi H, Ahn S, Lee BG, Chang I, Hwang JS. Inhibition of skin pigmentation by an extract of Lepidium apetalum and its possible implication in IL-6 mediated signaling. Pigment Cell Res 2005;18:439-446 (Pubitemid 41691459)
110. Haider K, Chachra KL, Sodhani P, Gupta S. Utility of imprint cytology for early presumptive diagnosis in clinically suspicious cervical cancer. Acta Cytol 2008;52:286-293 (Pubitemid 351705813)